Division of Biological Regulation and Oncology, Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Dis Colon Rectum. 2012 Mar;55(3):330-6. doi: 10.1097/DCR.0b013e3182417358.
Pouchitis is the most common long-term complication after restorative total proctocolectomy and IPAA for ulcerative colitis.
We examined the incidence, clinical aspects, and long-term outcome of patients with idiopathic pouchitis.
This study was a retrospective review of medical records.
Included in the study were 284 patients with ulcerative colitis who underwent a total proctocolectomy and IPAA.
We evaluated the cumulative risk and long-term outcome of pouchitis including the duration of disease, pattern of relapse, and responsiveness to antibiotic therapy.
Sixty-four patients developed idiopathic pouchitis. The cumulative risk was 10.7% at 1 year, 17.2% at 2 years, 24.0% at 5 years, and 38.2% at 10 years. At their first pouchitis episode, 45 patients had acute pouchitis, 19 patients had chronic pouchitis, and all patients received antibiotic therapy with oral ciprofloxacin and/or metronidazole. The efficacy of the therapy was 96.6% initially. Forty-five patients had antibiotic-responsive pouchitis, 17 patients had antibiotic-dependent pouchitis, and 2 patients had antibiotic-refractory pouchitis at their first episode. Whereas 20 of 45 patients (44.4%) with initially acute pouchitis experienced 2 or more relapses, 16 of 19 patients (84.2%) with initially chronic pouchitis had 2 or more relapses. After taking into account the relapses, the number of patients with antibiotic-responsive pouchitis decreased from 45 to 40, the number with antibiotic-dependent pouchitis increased from 17 to 20, and the number with antibiotic-refractory pouchitis increased from 2 to 4. Among the 4 patients with antibiotic-refractory pouchitis, 3 patients had Clostridium difficile-associated pouchitis.
This study was retrospective.
The patients with chronic pouchitis at the first episode tend to have a higher incidence of relapse. In some patients, the responsiveness to antibiotic therapy changes during follow-up. When patients with pouchitis do not respond to standard antibiotic therapy, then the occurrence of C difficile infection should be considered.
pouchitis 是溃疡性结肠炎患者接受直肠结肠切除回肠贮袋肛管吻合术后最常见的长期并发症。
我们研究了特发性 pouchitis 患者的发病率、临床表现和长期预后。
本研究为回顾性病历分析。
纳入研究的是 284 例溃疡性结肠炎患者,他们接受了直肠结肠切除回肠贮袋肛管吻合术。
我们评估了 pouchitis 的累积风险和长期预后,包括疾病持续时间、复发模式和对抗生素治疗的反应。
64 例患者发生特发性 pouchitis。1 年、2 年、5 年和 10 年的累积风险分别为 10.7%、17.2%、24.0%和 38.2%。在首次 pouchitis 发作时,45 例为急性 pouchitis,19 例为慢性 pouchitis,所有患者均接受口服环丙沙星和/或甲硝唑治疗。初始治疗的有效率为 96.6%。首次发作时,45 例为抗生素反应性 pouchitis,17 例为抗生素依赖性 pouchitis,2 例为抗生素难治性 pouchitis。20 例(44.4%)首次发作急性 pouchitis的患者中有 2 次或更多次复发,16 例(84.2%)首次发作慢性 pouchitis的患者中有 2 次或更多次复发。考虑到这些复发,抗生素反应性 pouchitis 的患者从 45 例减少至 40 例,抗生素依赖性 pouchitis 的患者从 17 例增加至 20 例,抗生素难治性 pouchitis的患者从 2 例增加至 4 例。在 4 例抗生素难治性 pouchitis 患者中,有 3 例为艰难梭菌相关性 pouchitis。
本研究为回顾性研究。
首次发作时为慢性 pouchitis 的患者更易复发。在一些患者中,对抗生素治疗的反应在随访过程中会发生变化。当 pouchitis 患者对抗生素标准治疗无效时,应考虑艰难梭菌感染的发生。